Cargando…

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial

Detalles Bibliográficos
Autor principal:	Aniwan, Satimai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Gastrointestinal Endoscopy 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995997/ https://www.ncbi.nlm.nih.gov/pubmed/35279974 http://dx.doi.org/10.5946/ce.2022.063

Ejemplares similares

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial
por: Jo, Hyeong Ho, et al.
Publicado: (2022)

Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease
por: Lee, Yeoun Joo, et al.
Publicado: (2022)

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
por: Chen, Fang, et al.
Publicado: (2021)

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
por: Kristensen, Vendel, et al.
Publicado: (2017)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type
por: Sonoyama, Hiroki, et al.
Publicado: (2019)

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis
por: Hu, Tingpeng, et al.
Publicado: (2023)

Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis
por: Li, Jiajia, et al.
Publicado: (2019)

Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study
por: Bertani, Lorenzo, et al.
Publicado: (2020)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
por: Kato, Riko, et al.
Publicado: (2022)

Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review
por: State, Monica, et al.
Publicado: (2021)

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?
por: Marais, Suzaan, et al.
Publicado: (2015)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
por: Lee, Yoo Min, et al.
Publicado: (2022)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Effects of Chili Treatment on Gastrointestinal and Rectal Sensation in Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blinded, Crossover Study
por: Aniwan, Satimai, et al.
Publicado: (2014)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
por: Lee, Sun-Ho, et al.
Publicado: (2017)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)

Systematic review on fecal calprotectin in cystic fibrosis
por: Lazzarotto, Eduarda Sampaio, et al.
Publicado: (2022)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
por: Riggers, Denise S., et al.
Publicado: (2023)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease
por: Mulak, Agata, et al.
Publicado: (2019)

Commentary: Tubercular posterior scleritis - Nuances in practice!
por: Murugan, Sivaraman Bala
Publicado: (2019)

Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
por: Bustinduy, Amaya L., et al.
Publicado: (2013)

Polymyositis Associated with Hepatitis B Virus Cirrhosis and Advanced Hepatocellular Carcinoma
por: Thanapirom, Kessarin, et al.
Publicado: (2014)

Current Status of Colorectal Cancer and Its Public Health Burden in Thailand
por: Tiankanon, Kasenee, et al.
Publicado: (2021)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Usefulness of Transcriptional Blood Biomarkers as a Non-invasive Surrogate Marker of Mucosal Healing and Endoscopic Response in Ulcerative Colitis
por: Planell, Núria, et al.
Publicado: (2017)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Diagnostic Value of Fecal Calprotectin in Patient with Ulcerative Colitis
por: Zamani, Hamed, et al.
Publicado: (2013)

A Study of Fecal Calprotectin in Obese Children and Adults
por: Park, Shin Young, et al.
Publicado: (2018)

Enteric Dysbiosis and Fecal Calprotectin Expression in Premature Infants
por: Ho, Thao T. B., et al.
Publicado: (2018)

COVID-19 and intestinal inflammation: Role of fecal calprotectin
por: Ojetti, Veronica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0pfq2urosa5sc802f8pgret1vv